Laura Lovett

By Laura Lovett 10:29 amSeptember 27, 2019
Shortly after acquiring telemedicine company HeyDoctor, GoodRx, a digital cost transparency tool for medication, announced it is launching its own virtual care platform dubbed GoodRx Care, powered by HeyDoctor.  The company is positioning the new platform as a primary care tool that will allow patients to see a board-certified clinician on the cheap — stating that “most visits” are about $20. Its...
By Laura Lovett 04:00 pmSeptember 26, 2019
British mental health startup Ieso Digital Health today announced a new research project dubbed Eight Billion Minds, which aims to use the data from its platform to build an autonomous digital therapeutic. The new effort will be specifically focused on creating a platform to tackle the shortage of mental health professionals globally.  Ieso’s signature product, ThinkWell, is a mental health...

Photo credit: Gabe Ginsberg/Getty Images for LARAS

By Laura Lovett 02:13 pmSeptember 26, 2019
23andMe, a frontrunner in the consumer genomics space, is turning its attention to clinical trial recruitment. The company has inked a deal with TrialSpark, a health tech platform that lets providers become clinical trial sites, connecting their customers to the latter’s trial network.  The new deal will use 23andMe’s crowdsourced research platform, which lets its customers opt into research and...
By Laura Lovett 04:22 pmSeptember 25, 2019
There’s no denying that digital therapeutics look and feel different than traditional medications. Instead of popping open a medication bottle, users are logging into an app to access treatment. But the differences don’t stop at the look. While the risk of toxicity is an ever-looming question in the pharma space, the same isn’t true for digital solutions.  Stakeholders at the digital therapeutics...
By Laura Lovett 01:21 pmSeptember 25, 2019
Behavioral health and wellness prediction company Catasys has inked a deal with banking firm Goldman Sachs to secure $45 million in debt financing.  WHAT THEY DO  Catasys uses artificial intelligence and data analytics to pinpoint health plan members who may have a behavioral health condition. The idea is to catch untreated mental illness before the issue becomes worse. The system then works on...
By Laura Lovett 04:03 pmSeptember 24, 2019
Getting the right diagnosis and prescription from a doctor is just one piece to the healthcare puzzle. How much food is at home and whether there is enough money in a patient’s bank account to cover the medication copay can be just as important to determining their medical outcomes.  Now hospital executives are starting to turn to technology as a way to help serve more patients and address social...
By Laura Lovett 03:52 pmSeptember 24, 2019
Boston Children’s Hospital spin-out Mightier has scored an additional $250,000 for its emotional regulation video game program. The new investment was made by Modern Time Group.  This additional funding comes on the heels on a $6.6 million Series A investment announced in May, which all together brings the company’s total money pot to roughly $10.35 million.  WHAT THEY DO  The company was created...
By Laura Lovett 02:15 pmSeptember 23, 2019
A Brazilian startup named TNH Health, which makes an artificial intelligence-enabled chatbot, announced a $2 million Series A funding round from Valor Capital Group and individual health entrepreneurs.  Founded in 2013, the company is headquartered in Rio Negrinho, Santa Catrina, Brazil, and has offices in Joinville and São Paulo. WHAT THEY DO The chatbot, dubbed Vitalk, will communicate with...
By Laura Lovett 02:09 pmSeptember 20, 2019
Canadian telemedicine company Maple has landed a cool $14.5 million CAD ($10.9 million USD) in a new funding round. German VC firm Acton Capital led the round, with participation from SE Health.  This news comes less than two years after the company closed a $4 million Series A funding round, which at the time the company said would be used for growth and expansion.  WHAT THEY DO Maple is a...
By Laura Lovett 02:54 pmSeptember 19, 2019
Sanofi has been active in the digital space this week inking two big deals: one with tech company Abbott and the other with digital platform Happify.  The first partnership with Abbott will combine the medtech company’s FreeStyle Libre, a continuous glucose monitoring system, and the pharma giant’s insulin dosing information to create smart pens and insulin titration apps.  Sanofi is currently...